As analysts start to give CVS a more favorable rating on Wall Street, the company’s shares are rising and as a result it’s beginning to close the valuation gap between marketing leader Walgreen.

Experts have previously been willing to pay more for potential profits from Walgreens Boots Alliance, however, with CVS shares pitting that of the market leader and with the former now being seen as a higher-risk, higher-reward play, CVS is seen as the lower-risk stock, according to Reuters.

Indeed, analysts are recommending CVS’ shares, with 85 percent placing ‘buy’ or ‘strong buy’ ratings on the stock as opposed to 58 percent for Walgreens – an indication of the nod towards CVS being a more secure option.